Circulating anticoagulants and acquired immunodeficiency syndrome
Aguilar Ligorit, E.; Alcacer García, E.; Marugan de la Concha, I.; García-Conde Bru, J.
Medicina Clinica 90(9): 392
1988
ISSN/ISBN: 0025-7753 PMID: 3393049 Document Number: 315514
Document emailed within 1 workday
Related Documents
Tsuchie, H.; Kawatani, T.; Nakayama, E.; Matsui, T.; Kurimura, T.; Hinuma, Y. 1985: Distribution of the level of antibody to acquired immunodeficiency syndrome associated virus in sera from acquired immunodeficiency syndrome related complex and japanese hemophiliacs infected with acquired immunodeficiency syndrome associated virus Microbiology and Immunology 29(11): 1083-1088Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674
Grunfeld, C.; Kotler, D.P.; Shigenaga, J.K.; Doerrler, W.; Tierney, A.; Wang, J.; Pierson, R.N.; Feingold, K.R. 1991: Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome American Journal of Medicine 90(2): 154-162
Borek, E.; Sharma, O.K.; Buschman, F.L.; Cohn, D.L.; Penley, K.A.; Judson, F.N.; Dobozin, B.S.; Horsburgh, C.R.; Kirkpatrick, C.H. 1986: Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome Cancer Research 46(5): 2557-2561
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Taillan, B.; Fuzibet, J.G.; Roul, C.; Vinti, H.; Pesce, A.; Bayle, J.; Cassuto, J.P.; Dujardin, P. 1989: Pathogenic significance of circulating anticoagulants in human immunodeficiency virus infection Presse Medicale 18(21): 1078
Ioachim, H.L. 1990: Biopsy diagnosis in human immunodeficiency virus infection and acquired immunodeficiency syndrome Archives of Pathology and Laboratory Medicine 114(3): 284-294
Seligmann, M.; Pinching, A.J.; Rosen, F.S.; Fahey, J.L.; Khaitov, R.M.; Klatzmann, D.; Koenig, S.; Luo, N.; Ngu, J.; Riethmüller, G. 1987: Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update Annals of Internal Medicine 107(2): 234-242
Strawford, A.; Hellerstein, M. 1998: The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome Seminars in Oncology 25(2 Suppl 6: 76-81
Appel, G.B.; Nicolaides, M.N. 1991: Human immunodeficiency virus/acquired immunodeficiency syndrome nephropathy in the inner city New York State Journal of Medicine 91(5): 207-210
Angadi, M.M.; Sorganvi, V.S.; Algur, V.S. 2013: Impact of health education on knowledge regarding human immunodeficiency virus/acquired immunodeficiency syndrome Journal of the Indian Medical Association 111(1): 28 30-1
Kalaajieh WK 2000: Epidemiology of human immunodeficiency virus and acquired immunodeficiency syndrome in Lebanon from 1984 through 1998 International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(4): 209-213
Garcia-Calleja, J.M.; Louis, J.P.; Salla, R.; Trebucq, A.; Mvondo, J.L.; Zekeng, L.; Migliani, R.; Owona, R.; Kaptue, L. 1993: Short term projections of infection by the human immunodeficiency (HIV) and the acquired immunodeficiency syndrome (AIDS) in Cameroon Medecine Tropicale: Revue du Corps de Sante Colonial 53(2): 195-199
Ndakotsu, M.A.; Salawu, L.; Durosinmi, M.A. 2009: Lupus anticoagulant in Nigerian patients living with human immunodeficiency virus/acquired immunodeficiency syndrome Journal of Microbiology Immunology and Infection 42(1): 69-73
Harris, C.; Small, C.B.; Klein, R.S.; Friedland, G.H.; Moll, B.; Emeson, E.E.; Spigland, I.; Steigbigel, N.H. 1983: Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome New England Journal of Medicine 308(20): 1181-1184
Wen, Y.; Li, C.; Pei, J.; Bai, J.; Yang, X.; Duan, K. 2014: The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China Zhonghua Kou Qiang Yi Xue Za Zhi 49(8): 454-458
Shen, M.C.; Hu, F.C.; Lin, J.S.; Hsie, S.W.; Hung, C.C.; Chung, C.Y. 1998: Human immunodeficiency virus infection in haemophiliacs in Taiwan: the importance of CD4 lymphocyte count in the progression to acquired immunodeficiency syndrome Haemophilia: the Official Journal of the World Federation of Hemophilia 4(2): 115-121
Chidzonga, M.Mapfumo.; Mahomva, L. 2008: Recurrent noma (cancrum oris) in human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV and AIDS): report of a case Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 66(8): 1726-1730
Johnson, F.Y. 1993: Psychiatric aspects of acquired immunodeficiency syndrome (AIDS)/human immunodeficiency virus (HIV) infection and sexually transmitted disease (STD): an overview Papua and new Guinea Medical Journal 36(3): 205-209
Budhachandra, Y.; Ramesh, K.; Sumitra, G. 2007: Personality profile among Human Immunodeficiency Virus (HIV) positives and Acquired Immunodeficiency Syndrome (AIDS) patients of injecting drug users Kathmandu University Medical Journal 5(1): 38-41